|
Mar 13, 2024
Meet the Vendors - Bonus Content
This session is structured by 2 presentations.
There is no Live Q&A Session for this module.
Please feel free to raise your questions in the final live session on April 11.
Overview
- From The Design to the Production of an Assay to Assess a Predictive Biomarker
- Molecular Biology Platform and Assays
- Software
- NGS Based Assay for Tissue and Liquid Biopsy Analysis
- How To Build a Companion Diagnostic Test
- Assay Accreditation: CLIA, ISO
- Liquid Biopsy in Clinical Trials: Integration and Design
Learning Objective
- To learn about the production process of an assay to assess predictive biomarkers.
- To know the functions, minimal requirements, procedures, and organization of a company developing molecular biology approach for biomarkers evaluation in Precision Medicine.
To receive the certification of this course, please make sure to complete all items below:
- Watch all videos of all 6 modules
- Answer more than 50% of questions from each Module
- Answer all post-module surveys (sent via email and link available on module pages) - see below
- Submit a short thesis after all modules are completed
Module 5 Post-Module Survey: https://docs.google.com/forms/d/e/1FAIpQLSfJsfLap-OiBIz5Hy9FDUcpzG-g1ZXc5iFTfn8Ji45rmJTH0g/viewform?usp=sharing
The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ISLB. The mention of any product, service, organization, activity, or therapy should not be construed as an ISLB endorsement.
Recent Episodes
Nov 01, 2025
Nov 23, 2024
Nov 21, 2023
Nov 30, 1999
David MacPherson
Nov 30, 1999
Kate Sutherland
Nov 30, 1999
Portia Thomas
Nov 30, 1999
Simon Heeke
Nov 30, 1999
Bruno Paiva
Nov 30, 1999
Catherine Meador
Nov 30, 1999
Carmen Garrido
Nov 30, 1999
Heather Wakelee
